XRCC6 and T-cell non-Hodgkin lymphoma: In Jurkat T cell lymphoma cells, silencing of Ku70 results in DNA damage accumulation, DDR impairment, reduction of cell proliferation, and induction of cell death; therefore, Ku70 can be a promising target in ATL cells [169].